Company: EDSA
Filing Date: 2025-09-09
Form Type: 424B5
Source: 0001171843-25-005799
Chunk: 32

Company: Edesa Biotech, Inc.
Filing Date: 2025-09-09
Form: 424B5
Chunk 32
---
 such Tax Proposals will be enacted
as currently proposed. No assurance can be given that the Tax Proposals will be enacted in the form proposed or at all. This summary does
not otherwise take into account or anticipate any changes in law, whether by way of legislative, judicial or administrative action or
interpretation, nor does it take into account tax laws of any province or territory of Canada or of any other jurisdiction outside Canada.

This summary is of
a general nature only and is not intended to be, nor should it be construed to be, legal or tax advice to any particular holder and no
representation with respect to the federal income tax consequences to any particular holder or prospective holder is made. The tax consequences
to a holder will depend on the holder’s particular circumstances. Accordingly, holders should consult with their own tax advisors
for advice with respect to their own particular circumstances.

For purposes of the Tax Act, all amounts
relating to the acquisition, holding and disposition of common shares, including dividends, adjusted cost base and proceeds of disposition,
must generally be determined in Canadian dollars using the applicable exchange rate quoted by the Bank of Canada for the relevant day
or such other rate of exchange that is acceptable to the CRA.**

#### Dividends
Amounts paid or credited or deemed to
be paid or credited as, on account or in lieu of payment, or in satisfaction of, dividends on the common shares to a Non- resident Holder
will be subject to Canadian withholding tax at the rate of 25% on the gross amount of such dividends unless the rate is reduced under
the provisions of an applicable income tax treaty or convention between Canada and the country of residence of the Non-resident Holder.
For example, under the Convention, the rate of Canadian withholding tax on dividends paid or credited by the Company to a Non-resident
Holder who is a resident of the United States for purposes of the Convention, is fully entitled to the benefits of the Convention, and
beneficially owns such dividends is generally 15% unless the beneficial owner is a corporation that owns at least 10% of the voting stock
of the Company at that time, in which case the rate of Canadian withholding tax is reduced to 5%.

| S-19 |

#### Dispositions
A Non-resident Holder will generally
not be subject to tax under the Tax Act on any capital gain realized on a disposition or deemed disposition of common shares, unless the
common shares constitute “taxable Canadian property” to the Non-resident Holder at